Background Beta-thalassemia is a severe genetic blood disorder caused by a mutation in
the gene encoding for the beta chains of hemoglobin. Individuals with beta-thalassemia …

Patients with beta (β)-thalassemia (β-TM: β-thalassemia major, β-TI: β-thalassemia
intermedia) have a variety of complications that may affect all organs, including the eye …

Purpose: To study the ocular manifestations in multiple transfused beta-thalassemia major
patients and assess the ocular side-effects of iron chelating agents. Materials and Methods …

Purpose To determine the prevalence and spectrum of ocular fundus abnormalities in
patients with β-thalassemia and to investigate risk factors for their development. Design …

Background Beta thalassemia (β-thalassemia) is a hereditary disease caused by defective
globin synthesis and can be classified into three categories of minor (β-TMi), intermedia (β …

Aims: The aim of this study was to assess ocular changes in thalassemia patients who have
received multiple transfusions and chelate binding therapy in order to avoid iron …

Background Ocular involvement may occur via several mechanisms in patients with
transfusion-dependent β-thalassemia (TDT) mainly chronic anemia, iron overload and iron …

Background Beta thalassemia major is an inherited blood disorder due to a mutation of the β
globin chain gene. Ocular complications have increasingly been reported in β-thalassemia …

AIM To investigate ophthalmologic findings in children with thalassemia major (TM) and
compare the findings with healthy controls. METHODS In a cross-sectional study, 43 …

Background: Thalassaemia major is associated with characteristic findings in craniofacial
bony structures and thereby may render abnormal bony orbit and subsequently distinctive …